Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Breast Diseases × Genotype × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1 Breast Diseases 1

Interventions

exemestane 4 entinostat 4 Fulvestrant 4 ribociclib 3 palbociclib 3 Anastrozole 3 abemaciclib 2 Letrozole 2 Gonadotropin-Releasing Hormone 2 AZD9833 2 tucatinib 1 pembrolizumab 1 ipatasertib 1 figitumumab 1 elacestrant 1 dactolisib 1 atezolizumab 1 Watchful Waiting 1 Trastuzumab 1 STX-478 1 RAD1901 1 Paclitaxel 1 Lapatinib 1 Genotype 1 Everolimus 1 Erlotinib Hydrochloride 1 Drug Therapy 1 Doxorubicin 1 Docetaxel 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05006196 2025-12-01

IMOGEN

Perspectum

Active not recruiting

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡